Efficacy and Safety of EGF / EGFR Vaccines in EGFR ‐Driven Solid Tumors: A Systematic Review and Meta‐Analysis of Controlled and Single‐Arm Studies

Documenti analoghi

• Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR ‐ TKIs ( ML41256 ): A Multicenter, Prospective, Single‐Arm, Phase 2 Trial
  di: Wenfeng Fang, et al.
  Pubblicazione: (2025)
• Multi‐Transcriptomic Analysis Reveals That EREG ‐Driven TME Crosstalk Defines Anti‐ EGFR Response in Colorectal Cancer
  di: Atsuki Taniguchi, et al.
  Pubblicazione: (2026)
• Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta‐Analyses
  di: Zhengyu Yu, et al.
  Pubblicazione: (2026)
• Assessing EGFR‐mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy
  di: Wei‐Chun Chen, et al.
  Pubblicazione: (2024)
• Efficacy of Almonertinib Versus Osimertinib as the First‐Line Treatment for Non‐Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study
  di: Xiujing Yao, et al.
  Pubblicazione: (2025)